AXP vs TSHA · P/E 20, rev $21.73B vs $640.7M cap
American Express Company (AXP) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the AXP and TSHA stock pages for the full models.
Not investment advice.